Pharmacology & Toxicology 1995-02-01

Comparison of high affinity binding of 3H-proadifen and 3H-(-)-cocaine to rat liver membranes.

S B Ross

Index: Pharmacol. Toxicol. 76(2) , 141-5, (1995)

Full Text: HTML

Abstract

The characteristics of the binding of 3H-proadifen to rat liver membranes were studied and compared to those of 3H-cocaine. It was found that 3H-proadifen was bound reversibly with high affinity (KD = 1.8 +/- 0.5 nM) and large capacity (Bmax = 2010 +/- 340 pmol/g wet tissue) to liver membranes. The corresponding values for the 3H-cocaine binding were 3.5 nM and 1000 pmol/g wet tissue. The binding of 3H-proadifen was mainly localised to the microsomal fraction. The number of binding sites was not increased by treatment of rats with phenobarbitone. With 1 microM CdCl2 in the incubation buffer it was possible to differentiate between two 3H-cocaine binding sites with Kd values of 1.6 and 7.7 nM and Bmax values of 280 and 940 pmol/g wet liver tissue. S-(-)-Alaproclate inhibited the binding of 3H-proadifen and 3H-cocaine with high affinity (IC50 = 2.2 nM and 0.4 nM, respectively). The R-enantiomer was 100 to 300 times less potent. Cocaine inhibited the binding of 3H-proadifen (IC50 = 10 nM) and proadifen that of 3H-cocaine (IC50 = 1 nM). There was a high correlation coefficient (rr = 0.972; P < 0.01; n = 12) in the Spearman rank test between the inhibitory potencies of compounds examined in both systems. Besides some potent alaproclate analogues a couple of compounds had moderately high affinity (IC50 = 100-500 nM): chloroquine, phenoxybenzamine, amitriptyline, ajmaline, remoxipride, imipramine and (-)-alaprenolol. CdCl2, ZnCl2 and CuCl2 inhibited the binding of both ligands with low Hill coefficients, indicating heterogeneous binding sites.(ABSTRACT TRUNCATED AT 250 WORDS)


Related Compounds

Related Articles:

The effects of increased serotonergic and decreased cholinergic activities on spatial navigation performance in rats.

1991-05-01

[Pharmacol. Biochem. Behav. 39(1) , 25-9, (1991)]

The effects of alaproclate and p-chlorophenylalanine on cued navigation performance in rats.

1992-01-01

[J. Neural Transm. Park. Dis. Dement. Sect. 4(1) , 43-52, (1992)]

Non-reversal of scopolamine- or age-related EEG changes by ondansetron, methysergide or alaproclate.

1991-01-01

[Psychopharmacology 103(4) , 567-70, (1991)]

Affinity and specificity of N-methyl- D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats.

2003-02-01

[Psychopharmacology 165(4) , 378-85, (2003)]

Effects of alaproclate, potassium channel blockers, and lidocaine on the release of 3H-acetylcholine from the guinea-pig ileum myenteric plexus.

1989-07-01

[Pharmacol. Toxicol. 65(1) , 25-32, (1989)]

More Articles...